Isn't PBT2 a Clioquinol derivative? Clioquinol was an antibiotic...

First 25 Last

Share
Profile

Follow
RickyH

25 Posts.

6

06/02/19

07:58

Post #: 37343334
Share

Originally posted by pivalde: ↑

This research paper is totally independent publication, no Prana's people. However, they must have given PBT2 to this group so Prana for sure knows that they have been testing PBT2. But perhaps Prana did not get very early any results (??). The paper was accepted in 5 days ( 5th of Nov) !!!!
It has been published on 11th of Dec, less than 2 weeks before trading halt, just when discussions with Sinclair have been going on and when SP has been going down and down.

In my opinion Prana did not understand the value of this paper before they made the deal with Sinclair, most likely they had not seen the paper before the trading halt (???). They should have made "negotiation halt" but when they did not do that it tells that they did not know the results.

I did not like the Sinclair deal ( too few millions, too much ownership) in spite Prana needs more money to get to the market. This new study with PBT2 is worth of millions for Prana in my understanding and so it may be that the Sinclair deal can still be avoided ( needs to be approved by owners). At least now Prana knows these new results and now it needs to try to sell PBT2 to some big pharma as an antibiotic to get the missing millions for PBT434. JMHO and everything is fore sure more complex.

Expand

Isn't PBT2 a Clioquinol derivative? Clioquinol was an antibiotic that was removed from the market because it caused myelo-optico-neuropathy. It is not surprising that PBT2 could have some antibiotic qualities and from my memory I think it has been investigated for this property before. I believe it was because of this checkered link that PBT2 needed to do the dog trials.

PBT Price at posting: 3.9¢ Sentiment: Hold Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

ASX Market Open: Aussie market to leap on best 'Trump trade' bump since election day | November 22, 2024

PCL

HotCopper users react as Pancontinental Energy's trading halt lift reveals little

CAF

IP anomaly thrills Cannidah with project extension hopes in QLD

CMB

Asian Battery Metals uncover second massive sulphide discovery at Mongolia's Oval play

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

ALY

Alcidion inks deal with Vic health provider Peninsula for use of Miya Precision tech

C1X

iTech inks deal with Chilean lithium giant to progress Reynolds Range

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

GRL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

There are more pages in this discussion • 71 more messages in this thread...

First 25 Last

Add PBT (ASX) to my watchlist

Isn't PBT2 a Clioquinol derivative? Clioquinol was an antibiotic...

Top Stories

ASX Market Open: Aussie market to leap on best 'Trump trade' bump since election day | November 22, 2024

HotCopper users react as Pancontinental Energy's trading halt lift reveals little

IP anomaly thrills Cannidah with project extension hopes in QLD

Asian Battery Metals uncover second massive sulphide discovery at Mongolia's Oval play

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Alcidion inks deal with Vic health provider Peninsula for use of Miya Precision tech

iTech inks deal with Chilean lithium giant to progress Reynolds Range

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Featured News